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n Service de Santé Au Travail Multisectoriel (STM), Luxembourg 
o NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, 1600–560 Lisbon, Portugal; Comprehensive Health Research 
Center (CHRC), 1169–056, Lisbon, Portugal 
p Public Health England, London, UK 
q Radboud Institute for Health Sciences, Radboudumc, Nijmegen, the Netherlands   







A B S T R A C T   
Exposure to hexavalent chromium [Cr(VI)] may occur in several occupational activities, e.g., welding, Cr(VI) 
electroplating and other surface treatment processes. The aim of this study was to provide EU relevant data on 
occupational Cr(VI) exposure to support the regulatory risk assessment and decision-making. In addition, the 
capability and validity of different biomarkers for the assessment of Cr(VI) exposure were evaluated. 
The study involved nine European countries and involved 399 workers in different industry sectors with ex-
posures to Cr(VI) such as welding, bath plating, applying or removing paint and other tasks. We also studied 203 
controls to establish a background in workers with no direct exposure to Cr(VI). We applied a cross-sectional 
study design and used chromium in urine as the primary biomonitoring method for Cr(VI) exposure. Addi-
tionally, we studied the use of red blood cells (RBC) and exhaled breath condensate (EBC) for biomonitoring of 
exposure to Cr(VI). Personal measurements were used to study exposure to inhalable and respirable Cr(VI) by 
personal air sampling. Dermal exposure was studied by taking hand wipe samples. 
The highest internal exposures were observed in the use of Cr(VI) in electrolytic bath plating. In stainless steel 
welding the internal Cr exposure was clearly lower when compared to plating activities. We observed a high 
correlation between chromium urinary levels and air Cr(VI) or dermal total Cr exposure. Urinary chromium 
showed its value as a first approach for the assessment of total, internal exposure. Correlations between urinary 
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E-mail address: tiina.santonen@ttl.fi (T. Santonen).  
Contents lists available at ScienceDirect 
Environmental Research 
journal homepage: www.elsevier.com/locate/envres 
https://doi.org/10.1016/j.envres.2021.111984 
Received 1 June 2021; Received in revised form 25 August 2021; Accepted 26 August 2021   
Environmental Research 204 (2022) 111984
2
chromium and Cr(VI) in EBC and Cr in RBC were low, probably due to differences in kinetics and indicating that 
these biomonitoring approaches may not be interchangeable but rather complementary. 
This study showed that occupational biomonitoring studies can be conducted successfully by multi-national 
collaboration and provide relevant information to support policy actions aiming to reduce occupational expo-
sure to chemicals.   
1. Introduction 
Hexavalent chromium (Cr(VI)) is an occupational carcinogen that 
may cause lung cancer in humans (IARC, 2012). Positive associations 
have been observed between Cr(VI) exposure and cancers of the nose 
and nasal sinuses (IARC, 2012) and there are also concerns related to 
other respiratory tract cancers and to gastrointestinal track cancers 
(Deng et al., 2019; ECHA, 2013). In addition, occupational exposure to 
Cr(VI) is a common cause of asthma, allergic dermatitis and there is a 
concern of reproductive effects. Exposure to Cr(VI) may occur in several 
occupational activities, i.e. welding, Cr(VI) electroplating and other 
surface treatment processes such as paint application and removal of old 
paint containing Cr(VI) (SCOEL, 2017). Soluble hexavalent compounds, 
like chromium trioxide, sodium or potassium dichromate are used in 
chrome plating in baths (electroplating) but can be used also in surface 
treatment by spraying, brush or pen applications or in passivation pro-
cesses. Sparingly soluble strontium chromate and zinc chromate hy-
droxide are used in chromate paints for example in the aviation sector 
(ECHA, 2021). Welding and flame cutting of stainless steel leads to 
ultra-fine and nano-sized chromium oxide particles in both trivalent and 
hexavalent form. Composition of welding fumes is determined to a great 
extent by the technique used, with manual metal arc (MMA) producing 
more Cr(VI) emissions than metal inert gas (MIG) or tungsten inert gas 
(TIG) techniques (IARC, 2012; Scheepers et al., 2008). Differences in the 
type of Cr(VI) emissions, including solubility of the Cr(VI) compounds 
and size of the particles, affect the probability of exposure, the exposure 
routes, and the toxicokinetics of Cr (Wilbur et al., 2012). 
Occupational exposure to Cr(VI) is currently regulated in EU under 
both the European regulation (EC, 1907/2006) on the Registration, 
Evaluation, Authorization and Restriction of Chemicals (REACH) and 
the EU Directive 2004/37/EC on the protection of workers from the risks 
related to exposure to carcinogens or mutagens at work (EU, 2004). The 
recent binding Occupational Exposure Limit (OEL) set under EU Direc-
tive 2004/37/EC is 10 μg/m3 (8-h time-weighted average (8-h TWA)) 
until January 17, 2025; after that period, the OEL (8-h TWA) will be 
limited at 5 μg/m3. For welding, plasma-cutting processes and similar 
work processes that generate fumes, there is a derogation with an OEL 
value of 25 μg/m3 (8-h TWA) until 5 years after the transposition date of 
2017; after that period, the OEL (8-h TWA) of 5 μg/m3 will also be 
applicable. France and the Netherlands have even stricter limits with an 
OEL of 1 μg/m3 (8-h TWA) for Cr(VI) in all uses (Décret, 2012; MinSZW, 
2016). From other European countries, Denmark has also implemented 
an OEL of 1 μg/m3, which is planned to be lowered further to 0.25 μg/m3 
if technically and economically feasible (Beskæftigelsesministeriet, 
2020). In US, ACGIH has proposed an updated threshold limit value 
(TLV) of 0.2 μg/m3 (8-h TWA) for Cr(VI) based on the respiratory tract 
effects of Cr(VI) (ACGIH, 2021). 
In occupational health, urinary total chromium (U–Cr) is currently 
the most often used biomarker for the assessment of exposure to Cr(VI). 
No EU-wide biological limit value (BLV) has been set for U–Cr in Europe, 
but some Member States have defined national BLVs for occupational 
exposure to Cr(VI) measured as U–Cr. For example, France and Finland 
have derived BLVs of 2.5 μg/l and 10 μg/l corresponding to their 
respective OELs of 1 μg/m3 and 5 μg/m3 for Cr(VI) (ANSES, 2017; STM, 
2020). The Spanish authorities have adopted the ACGIH BEI® level of 
10 μg/l for U–Cr measured during a shift and 25 μg/l at the end of the 
last shift of the workweek as their BLV (INSHT, 2019). UK has adopted 
biological monitoring guidance value (BMGV) of 10 μmol/mol 
creatinine (ca. 6.3 μg/l) in post-shift urine (HSE, 2018). The German 
DFG (DFG, 2020) has established biological exposure equivalents for 
carcinogenic substances (EKA values), ranging from 12 to 40 μg/l for 
U–Cr at the end of shift and from 9 to 35 μg/l in the erythrocyte fraction 
of whole blood at the end of the shift in the end of the work week. These 
urinary values correspond to exposures ranging between 30 and 100 
μg/m3 soluble alkaline chromate and/or Cr(VI) containing welding 
fumes over an 8 h work shift (Bolt and Lewalter, 2012). The main lim-
itation of U–Cr is that it is not specific for Cr(VI) since it reflects exposure 
to both Cr(III) and Cr(VI). Therefore, there has been a need to develop 
additional biomarkers that are more specific in quantifying Cr(VI) 
exposure, such as Cr in red blood cells (RBC) (Lewalter et al., 1985) and 
Cr(VI) in exhaled breath condensate (EBC), respectively (Goldoni et al., 
2010; Leese et al., 2017). 
The European human biomonitoring initiative (HBM4EU) (www. 
hbm4eu.eu/about-hbm4eu/) is a joint effort of 30 countries, the Euro-
pean Environment Agency and the European Commission which uses 
biomonitoring to assess human exposure to chemicals in Europe, so to 
better understand the associated health impacts and to improve chem-
ical risk assessment (Ganzleben et al., 2017). Within HBM4EU, Cr(VI) 
was defined as one of the priority compounds at European level (Ormsby 
et al., 2017). The HBM4EU chromates study was designed to address the 
concerns related to the occupational exposure to hexavalent chromium. 
The main aim was to provide EU relevant data on occupational Cr(VI) 
exposure to support the regulatory risk assessment and decision-making. 
In addition, the capability and validity of different biomarkers for the 
assessment of Cr(VI) exposure were evaluated in a harmonized way and 
under quality assurance/quality control measures. 
The present paper describes the overall results of the HBM4EU 
chromates study and the main recommendations regarding the moni-
toring of occupational exposure to Cr. Follow-up publications (in prep-
aration) will describe specific data sets in more detail, regarding the 
applicability of different types of biomarkers and matrices, as well as the 
effectiveness of the different risk management measures (RMMs) 
available for different processes. 
2. Materials and methods 
The HBM4EU chromates study was designed as a multi-center cross- 
sectional survey, carried out originally in eight countries, i.e. Belgium, 
Finland, France, Italy, Poland, Portugal, the Netherlands and the United 
Kingdom. At a later stage, Luxembourg joined the study as a ninth 
participating country. Sampling protocol has been described in detail in 
(Santonen et al., 2019). Detailed Standard Operating Procedures (SOPs) 
(Santonen et al., 2019), providing information on the collection, 
handling, storage and transfer of the biological and occupational hy-
giene samples, were designed to allow the study team to perform data 
collection in a harmonized way, resulting in comparable data for the 
nine participating countries. All the samplings were performed between 
October 2018 and December 2020. 
2.1. Study population 
Exposed workers were recruited from companies with activities that 
are known to be associated with occupational exposure to Cr(VI), more 
specifically (i) chrome plating, (ii) surface treatment by sanding, 
spraying or painting, and (iii) stainless-steel welding. Unexposed 
workers were recruited either within the same company, but from 
T. Santonen et al.                                                                                                                                                                                                                               
Environmental Research 204 (2022) 111984
3
activities that are known not be associated with Cr(VI) exposure (for 
example office staff) (“within company controls”), or from other com-
panies with no activities associated with Cr(VI) exposure (“outwith 
company controls”). Recruitment of the companies and workers fol-
lowed the dedicated SOP for the selection of participants, recruitment, 
informing participants and obtaining informed consent. Common in-
formation leaflets and informed consent forms were developed and 
translated in the national languages (English, Finnish, French, Polish, 
Italian, Portuguese, Dutch and German). Study protocols were submit-
ted for approval by ethics review boards in each of the participating 
countries with the approvals being granted before recruiting the study 
participants (Santonen et al., 2019). 
2.2. Questionnaires 
Two questionnaires were used to collect relevant contextual infor-
mation. The first questionnaire was completed by a company repre-
sentative, prior to the sampling campaign, in order to collect general 
information on the workplace and operating conditions and RMMs 
adopted. The second questionnaire was completed by the researcher 
while interviewing the worker as close as possible to the end of work 
shift, and included detailed description of job activities, specific work 
tasks performed during the day, RMMs used in different tasks and work 
organization during the days of sampling. The questionnaire also 
included questions on the workers’ background exposure to Cr(VI) from 
other sources due to e.g. air pollution related to the place of residence, 
living habits, smoking, implants, and food supplements. 
2.3. Air and dermal sample collection and Cr analysis 
For electroplaters and surface treatment workers, simultaneous 
sampling of the inhalable and respirable fractions of Cr(VI) and total Cr 
was performed following specific guidance (CEN, 1993). Personal 
inhalable dust measurements were obtained using an IOM sampling 
head (flow rate 2 l/min), whereas for the respirable dust fraction mea-
surements were obtained using the Higgins Dewell type (flow rate 2.2 l/ 
min) or similar cyclone sampling heads. The sampling head cassettes 
were loaded with pre-weighed 25 mm PVC-filters (GLA-5000) or MCE- 
filters. These measurements were done outside the respiratory protec-
tive equipment (RPE), in the breathing zone of the workers. 
For welders, alternatively the SKC Mini-sampler was used, loaded 
with a pre-weighed 13 mm MCE filter, at a flow rate of 0.75 l/min, with 
this being positioned under the welding visor. These SKC mini-samplers 
were used only by UK, Belgium and Luxembourg for the collection of 
total Cr. Also the few Cr(VI) samples collected under the RPE were 
collected using SKC mini-samplers. All the samples were collected for a 
representative period of the work shift. 
The air samples were analysed gravimetrically for determination of 
the dust fraction and then analysed for total Cr using OSHA Method ID- 
125G (OSHA, 2002) and Cr(VI) using ISO 16740 Method (ISO, 2005) 
and NIOSH Method 7600 (NIOSH, 2015). Only the results of the Cr(VI) 
analysis are presented in this manuscript. The other results will be 
presented in subsequent manuscripts. 
Dermal wipe samples were collected using SKC Ghost sampling 
wipes (or similar lead wipes) (NIOSH, 2003; OSHA, 2002). Samples 
were collected at set periods during the working shift (pre-shift, first 
break period, lunch and post-shift). At each sampling period, a stan-
dardized wiping procedure was applied. Using a separate wipe for each 
hand, five horizontal and five vertical wipes across the surface of the 
palm of the hand (including the fingers) were made, followed by a wipe 
in the clockwise direction. This procedure was repeated for the dorsal 
hand region, with each finger then being wiped. The wipes were ana-
lysed for total Cr using OSHA Method ID-125G (OSHA, 2002). Average 
hand areas of 535 cm2 per male hand (total 1070 cm2 for both hands) 
and 445 cm2 per female hand (total 890 cm2 for both hands) (EPA, 2011) 
were used in subsequent calculations. 
2.4. Blood and urine sample collection and Cr analysis 
All countries, except UK, collected blood samples for RBC-Cr ana-
lyses. Blood samplings were preferentially performed on the 3rd - 5th 
day of the working week. One blood sample was collected in a tube with 
potassium ethylenediamine tetra acetic acid (K-EDTA) appropriate for 
trace elements analyses from each (exposed or non-exposed) participant 
and was kept at +4 ◦C until analysis. To avoid haemolysis, plasma and 
RBC separation was conducted, preferably within 8 h (and maximum 24 
h) from the specimen collection, following the method described by 
Devoy et al. (2016). Samples were centrifuged (10 min at 1000–2000×g 
or 5 min at 2700×g) and the supernatant containing the plasma and 
white blood cells was used for Cr analyses (storage at +4 ◦C up to 7 days 
or − 20 ◦C for longer periods). The pellet underwent three washing steps 
with 0.9% NaCl solution (with a volume corresponding the initial vol-
ume of blood collected), in order to eliminate interfering plasma/Cr 
residues. The hematocrit (HT) values (measured before (HT1) and after 
the washing steps (HT2)) were measured to indicate RBC loss during 
washing steps and the final results were corrected for HT2. After the last 
washing step, the tube containing RBCs was filled up with 1% Triton 
X-100 in deionised water/0.2% HNO3 (or 0.2% NH4OH depending on 
the technique used) up to the initial volume. RBCs were then stored at 
room temperature up to 3 days or at − 20 ◦C for up to 3 months. 
Two spot urine samples were collected from the exposed workers, the 
first before the start of the shift at the beginning of the working week, 
and the second one at the end of the shift in the end of the working week 
(typically on Thursday or Friday). To avoid contamination of urine 
samples, participants were instructed to remove their work clothes and 
to thoroughly wash their hands before the urine collection. One spot 
urine sample was collected from the control individuals at any time of 
the working week. Urine samples were collected in previously decon-
taminated containers (e.g. pre-washed with 10% of nitric acid solution) 
to avoid background contamination. After collection, urine samples 
were homogenized and aliquoted in several pre-labeled tubes and stored 
at − 20 ◦C. Urinary creatinine concentrations were measured and Cr 
results were normalized to creatinine. 
According to the WHO (WHO, 1996) the acceptable creatinine con-
centration range of the urine specimen is 0.3–3.0 g/l, although data to 
justify these limits is hard to find. We tested the Spearman correlations 
of original, un-adjusted urinary Cr data both with all creatinine cor-
rected Cr data and with creatinine corrected Cr data including only those 
within the aforementioned ‘acceptable creatinine range’ for both 
workers and controls. There were only marginal differences in correla-
tion between these two test groups - in all cases the Spearman correla-
tion coefficient was either high (0.7–0.8) or very high (0.9). 
Accordingly, no data were discarded according to low/high creatinine 
concentration. 
All the laboratories analyzing the blood and urine samples had suc-
cessfully passed ICI (Interlaboratory Comparison Investigations) rounds 
within the HBM4EU Quality Assurance (QA) program (Esteban Lopez 
et al., 2021; Nübler et al., 2021). 
2.5. Exhaled breath condensate (EBC) sample collection and Cr analysis 
EBC was collected using the TurboDECCS system (Medivac, Parma 
Italy). Two EBC samples were collected from exposed workers; the first 
before the start of shift on the first day of the working week and a second 
sample at the end of the shift in the end of the working week (typically 
on Thursday or Friday). For the control group only one EBC sample was 
collected during the working week. 
To inhibit the degradation or interconversion of Cr(III) and Cr(VI), 
the EBC samples were complexed with an EDTA solution and stored 
refrigerated (not frozen). Immediately after the collection of each EBC 
sample, an aliquot of EBC was diluted 10-fold with 0.5 mM EDTA (pH 
adjusted to pH 8 using 10% v/v ammonia solution). The volume of EBC 
collected can vary from one individual to another, and consequently the 
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concentration of Cr(VI) may also vary. As there is currently no proposed 
volume correction marker, the results were reported in μg/L per volume 
of EBC collected. In order to do this, the amount of EBC sample aliquoted 
to be complexed with the EDTA solution was recorded, and the 
remainder of the uncomplexed EBC sample was weighed upon return to 
the analysing laboratory. 
Supplementary Table S1 gives an overview of the methods used to 
measure Cr in the different matrices, by country. 
2.6. Data management and analyses 
A harmonized codebook, accompanied by a Microsoft Excel 
(Microsoft, Redmond, Washington, US) data template, was provided to 
the research teams to insert study data to allow for pooling of the data 
for analysis. This data template included information from both the 
questionnaires and the analytical results (blood, urine, EBC, air and 
wipes). After minor spreadsheet calculations and data cleaning, the final 
data template was imported into IBM© SPSS© Statistics software 
(version 25/27, IBM Corporation, NY, US) for statistical analysis. 
Descriptive statistics including geometric mean (95% CI), arithmetic 
mean, median, and percentile levels (P5, P25, P75, P95) were calcu-
lated. Shapiro-Wilk test, Mann-Whitney U test, Wilcoxon signed-rank 
test, and Spearman Rank Correlation were applied for the statistical 
analysis of the data. p-Values of <0.05 were considered statistically 
significant. All data with n > 10 followed a log-normal distribution. For 
data with n < 10, the sample distribution could not be reliably deter-
mined. Shapiro-Wilk test was used to test for normality of the data, 
Mann-Whitney U test was used to compare two independent sample sets 
(like urinary concentrations of workers and controls), and Wilcoxon 
signed-rank test was used to compare two dependent sample sets (like 
pre-shift and post-shift urinary concentrations of the same workers). 
Values below the limit of quantification (LOQ) were substituted by 
LOQ/2 during the statistical processing (Hornung and Reed, 1990). 
Where >50% of results were below LOQ, statistics were not presented. 
Box plots were prepared using Stata Statistics/Data analysis software 
(version 15.1, StataCorp LLC, TX, US). 
3. Results 
3.1. Description of the study population and the samples collected 
A total of 602 workers, including 399 exposed workers and 203 
controls gave their informed consent to participate in the study. Exposed 
workers were mainly men (98%), whereas in controls, the ratio men/ 
women was approximately 3:1 (73% vs. 27%). Exposed workers were on 
average 42 ± 11 years old (mean ± SD) and controls 44 ± 10 years. A 
total of 164 (29%) participants were smokers (smoking data were 
missing from 8 persons); this proportion being higher in the exposed 
workers (35.4%, n = 139) as compared to the controls (12.4%, n = 25). 
Characteristics of the study population is described more in detail in 
Table 1. 
Original categorization of workers was made according to the sectors 
that were primarily targeted in the recruitment, i.e. chrome plating in 
baths, surface treatment by e.g. using chromate containing paints, and 
stainless-steel welders. However, there were some participants who 
were performing other specific jobs which could not be grouped under 
these three categories. These workers were categorized as workers 
mainly engaged in machining work in chrome plating or surface treat-
ment companies; thermal spraying workers (coating process in which 
heated metallic Cr is sprayed onto a surface with possible formation of 
Cr(VI) fumes); steel production workers (involved in operating cold strip 
mill, in pickling and annealing process); and finally, maintenance and 
laboratory workers in chrome plating or surface treatment companies. 
Distribution of the participants in groups according to these work ac-
tivities are presented in Table 1. Table 2 presents the number of samples 
collected for each work activity. The task distribution covered by the 
monitoring campaigns varied among the countries, with some countries 
involving mainly welders and others primarily bath platers or workers 
performing paint applications. This was dependent on the types of 
companies and workers willing to participate in the study in each 
country. Work distribution by country is presented in Supplementary 
Table S2. 
Control workers were either office workers recruited from the same 
companies as the exposed workers (n = 147, referred to “within com-
pany controls”), or from other companies with activities known not to be 
associated with Cr(VI) exposure (n = 56, referred to “outwith company 
controls”). 
Supplementary Table S3 gives an overview of the total number of 
samples that were collected from each participating country of the 
HBM4EU Chromates study. The main focus of the study was to collect 
exposure data based on biomonitoring from different occupational sec-
tors. The U–Cr was the main parameter, which was collected from all the 
exposed workers in all countries. For the study of the usefulness of other 
exposure biomarkers, RBC-Cr and EBC-Cr(VI), samples were not 
collected in all countries. This explains the lower numbers of RBC-Cr and 
EBC-Cr(VI) samples when compared to the numbers of U–Cr samples. 
Industrial hygiene samples were collected to identify the main 
exposure routes to chromium in the different exposure scenarios 
considered. The final numbers of different types of air measurements 
were dependent on the workplace and country specific aspects, 
including technical resources. Although all countries collected air sam-
ples, three countries measured only total Cr. From other countries, a 
total of 194 personal inhalable Cr(VI) samples were collected. In France, 
Finland and the Netherlands personal respirable Cr(VI) measurements 
were also performed (n = 91 samples). Only few samples were collected 
inside the RPE, mainly from welders (Table S3, data on these mea-
surements not presented). The number of wipe samples collected per 
worker was dependent on the length of work task involving exposure to 
Cr and number of breaks/hand washings during the shift. A minimum of 
two and a maximum of 6 wipe samples were collected per worker. Not 
all workers provided wipe samples. Total number of workers providing 
wipe samples was 267 (from 8 countries, Table 2 and Supplementary 
Table S3). The number of industrial hygiene samples collected from 
different work activities are presented in Table 2. 
Table 1 
Characteristics of the study population.   
Total number Age (years), mean ± SD Males Females Smokers Non-smokers (smoking status not available) 
Control workers 203 44 ± 10 148 55 25 176 (2) 
All Exposed Workers 399 42 ± 11 390 9 139 254 (6) 
Bath plating workers 90 43 ± 11 88 2 40 49 (1) 
Chromate Paint applications 52 42 ± 9 49 3 16 32 (4) 
Welders 195 41 ± 11 194 1 63 131 (1) 
Machining workers 38 42 ± 10 38 0 13 25 
Steel production 11 45 ± 7 11 0 3 8 
Thermal sprayers 5 41 ± 6 5 0 2 3 
Maintenance and laboratory workers 5 50 ± 11 5 3 2 6  
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3.2. Determination of Cr in the biological samples (blood, urine and EBC) 
3.2.1. Background levels in control subjects 
U–Cr, RBC-Cr and EBC-Cr(VI) levels in the control population are 
presented in Table 3. The high levels observed in some control subjects 
raised the question of whether the controls recruited from the companies 
with processes involving exposure to Cr(VI) were really unexposed. 
When analysing separately the data from the “within company controls” 
(i.e. from the companies involving the use of Cr(VI)) and “outwith 
company controls” (from companies not using Cr(VI)) we observed that 
the “within company controls” showed statistically significantly higher 
U–Cr and RBC-Cr levels as compared to the “outwith company controls” 
(Table 3). Although the median RBC-Cr level was higher in “outwith 
company controls” when compared to the within company levels (p =
0.003, Mann-Whitney test), P95 level was clearly higher in “within 
company controls” (Table 3). Similarly, also AM and e.g. P75 levels were 
clearly higher in “within company controls” when compared to “outwith 
company controls” (AM 1.53 and 1.32 and P75 3.62 μg/l and 1.50 μg/l, 
respectively). This suggests that the “within company control” group 
included some individuals with high exposure to Cr. Table 3 includes 
also previous occupationally non-exposed population U–Cr data from 
Italy and UK that did not collect urine Cr samples for this study due to 
their already existing data on U–Cr levels in the occupationally non- 
exposed population. EBC-Cr levels in “outwith company controls” 
were all below the LOQ but nine of the 67 “within company controls” 
(13%) showed levels above the LOQ. Control groups included samples 
up to 21 current smokers, whose chromium levels did not differ signif-
icantly from non-smokers (data not shown). U–Cr and RBC-Cr levels in 
control workers showed small but inconsistent gender-related differ-
ences: median and P95 RBC-Cr levels in control females (n = 48) were 
0.45 and 5.32 μg/l and in males (n = 127) 0.64 and 4.69 μg/l whereas 
creatinine corrected pre-shift U–Cr median and P95 levels in females (n 
= 38) were 0.28 and 1.97 μg/g creatinine and in males (n = 97) 0.19 and 
0.96 μg/g creatinine. This difference in U–Cr was statistically significant 
(p < 0.05, Mann-Whitney test). 
3.2.2. Urinary chromium in exposed workers 
Fig. 1 presents the concentrations of U-Cr in the exposed workers and 
controls for the main worker groups (with >10 post-shift U–Cr results). 
For the exposed workers, both pre- and post-shift U–Cr are presented. 
Pre-shift levels of all worker groups, except for small groups of thermal 
sprayers and maintenance and laboratory workers, were significantly 
higher when compared to the levels observed in the controls (Mann- 
Whitney test, p ≤ 0.001, all controls). As compared to the control 
groups, all worker groups showed significantly increased post-shift U–Cr 
levels (Fig. 1). The highest exposure levels were observed in chrome 
plating in baths. This was the case both for U–Cr pre-shift (median 0.77 
μg/g creatinine, P95 4.99 μg/g creatinine) as well as for U–Cr post-shift 
(median of 1.12 μg/g creatinine and P95 of 7.70 μg/g creatinine). 
Among the 189 welders studied, 24 (13%) reported welding of other 
materials than stainless steel on the day of urine sampling. Exclusion of 
these 24 workers had, however, only minimal impact on the results: 
median and P95 post-shift U–Cr levels for all welders were 0.68 and 
3.36 μg/g creatinine, and when these 24 welders were excluded the 
respective levels were 0.70 and 3.14 μg/g creatinine, respectively. 
Within the total group of the exposed workers, post-shift U–Cr was 
significantly higher than pre-shift U–Cr for all worker groups except 
thermal sprayers, maintenance and laboratory workers (Wilcoxon test, 
p ≤ 0.01). Median and P95 ΔCr levels (post-shift minus pre-shift within 
the same person) for all the workers combined was 0.20 and 2.58, 
respectively, for chrome plating in baths 0.31 and 4.06, for paint ap-
plications 0.12 and 2.58, and for machining workers 0.36 and 4.20, 
respectively. P10 was either negative or almost zero in all worker groups 
(− 0.46–0.003) which reflects the negligible exposure of a proportion of 
the workers during the time of sampling. In occupational health, refer-
ence values (usually set to correspond the 95th percentile of the non- 
Table 2 
Work distribution of the participants of the HBM4EU Chromates study and number of samples collected for each work activity.   
Total number of 
workers 














Bath plating workers 90 90 90 70 65 57 54 77 
Chromate paint 
applications 
52 52 45 48 0 7 0 32 
Machining workers 38 38 36 35 21 15 10 25 
Welders 195 193 189 171 81 107 20 115 
Thermal spraying 5 5 5 5 5 5 5 5 
Steel production 11 11 10 9 0 0 0 5 
Maintenance and 
laboratory workers 
8 8 8 7 3 3 2 8 
All exposed workers 399 397 383 345 175 194 91 267 
Within company controls 147 94 – 134 67 – – – 
Outwith company 
controls 
56 41 – 41 31 – – – 
All controls 203 135 - 175 98 - - - 
All participants 602 532 383 520 273 194 91 267  
a Number of workers sampled (2–6 wipe samples per worker). 
Table 3 
Exposure biomarker levels in controls and in the earlier studies from Italy and UK.   
U–Cr median, P95 RBC-Cr median, P95 EBC Cr(VI) median, P95 
μg/g creatinine μg/l μg/l 
All controls 0.22, 1.35 (n = 135) 0.63, 5.00 (n = 175) <LOQ, 0.05 (n = 98) 
Within company controls 0.31, 1.39 (n = 94 *) 0.38, 5.06 (n = 134) ** <LOQ, 0.07 (n = 67) 
Outwith company controls 0.11, 0.44 (n = 41) 1.02, 3.12 (n = 41) <LOQ (n = 31) 
Morton et al. (2014) (UK) 0.42, 1.31 (n = 132) – – 
Aprea et al. (2018) (Italy) 0.218 (GM)#, 0.963 (n = 260) – – 
Significant difference between within company controls vs outwith company controls *p < 0.001, **p = 0.003, #median level not available. 
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occupationally population levels) are generally used to discriminate 
occupational exposure from the background exposure. Therefore, to 
better put the results into perspective, we have compared the post-shift 
U–Cr results of different worker groups to the 95 percentiles of controls 
(Table 4, first and second column). In addition, we have compared post- 
shift U–Cr in different worker groups with the BLVs for U–Cr available 
from France (2.5 μg/l or 1.8 μg/g creatinine, corresponding to an OEL 
for Cr of 1 μg/m3) and from Finland (10 μg/l or 7.8 μg/g creatinine, 
corresponding to an OEL for Cr of 5 μg/m3). These results are also given 
in Table 4, in columns three and four. As can be seen from Table 4, 78% 
of the workers in chrome bath plating had post-shift U–Cr levels greater 
than the P95 of the outwith company controls and 40% exceeded the 
P95 of all controls (within company and outwith company controls 
combined). Thirty four percent of the post-shift U–Cr levels in bath 
platers exceeded the French BLV of 1.8 μg/g creatinine, whereas these 
proportions were varying between 18% and 24% for other worker 
groups except for the workers performing maintenance and laboratory 
activities where no exceedances were observed. Five samples exceeded 
the Finnish BLV of 10 μg/l (corresponding 7.8 μg/g creatinine). 
3.2.3. Cr in red blood cells (RBC-Cr) 
Fig. 2 shows results on RBC-Cr measurements. Only groups of 
workers with >10 RBC-Cr results are presented. Chrome plating workers 
showed the highest levels of RBC-Cr with a median of 4.34 μg/l and P95 
level of 8.88 μg/l. These levels were significantly higher when compared 
to the both control groups (p < 0.001, Mann-Whitney test). Similarly, 
machining workers (showing median and P95 levels of 3.3 and 5.36 μg/ 
l) showed statistically significantly higher levels of RBC-Cr when 
compared to both control groups (Fig. 2). Maintenance and laboratory 
workers had also slightly higher levels of RBC-Cr compared to the both 
control groups but due to the small group size (n = 7) no clear conclu-
sions can be drawn from this (data not shown). Welders (median and 
P95 RBC-Cr levels 0.40 and 5.18 μg/l) did not show increased exposure 
to Cr when compared to the control groups (median level was actually 
statistically significantly lower when compared to the outwith company 
controls). In chromate painting applications the levels showed border-
line statistical significance when compared to within company controls 
but remained below the statistical significance when compared to out-
with company controls or both control groups combined (p = 0.103, 
Mann-Whitney test). 
3.2.4. Cr(VI) in exhaled breath condensate 
EBC-Cr(VI) levels in controls remained generally below LOQ (see 
Table 3). Of all bath plating workers 67% showed EBC-Cr(VI) levels 
above LOQ, median EBC-Cr(VI) in post-shift samples being 0.05 and P95 
1.95 μg/l for bath platers. In bath platers it was possible to detect 
measurable Cr(VI) levels also in pre-shift samples in 59% of cases, me-
dian and P95 pre-shift levels being 0.02, 0.62 μg/l, respectively. No EBC- 
Cr(VI) data was available from paint applications. Welders and 
machining workers had measurable EBC-Cr(VI) levels (above LOQ) only 
in 26% and 14% of cases and therefore, no statistics were applied. In 
thermal spraying, EBC-Cr(VI) levels remained below LOQ (n = 5). 
3.2.5. Cr(VI) in the industrial hygiene samples (air, wipes) 
In Table 5 the Cr(VI) air measurement results in different worker 
groups are presented. Subsequent manuscripts (in preparation) will 
discuss the additional air sampling results obtained during the mea-
surement campaigns. It should be, however, noted that all of the tasks 
Fig. 1. Distribution of U-Cr in controls and in exposed workers (pre-shift, post-shift). * Pre-shift vs. within company controls, ** pre-shift vs. outwith company 
controls, # post-shift vs both within company controls and outwith company controls, ## post-shift vs. pre-shift. Box plots: The bottom and top of the box are, 
respectively, the 25th and 75th percentiles, and the horizontal line inside the box is the median (50th percentile). The lower and upper ends of the whiskers are the 
5th and 95th percentiles, respectively. The solid diamond is the geometric mean. 
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involved exposure also to Cr(III). For example, in plating median and 
95th percentile levels were 9.85 and 358.75 μg/m3 for total inhalable Cr, 
respectively (outside RPE). In welding, median and 95th percentile 
levels were 16.10 and 481 μg/m3 for total inhalable Cr outside RPE, 
respectively. 
Fig. 3 shows the results from hand wipe samplings. In all the occu-
pational groups, significant dermal Cr accumulation over the workday 
could be determined. The highest cumulative Cr levels were demon-
strated in welders and chrome bath platers. Thermal sprayers had 
significantly higher dermal contamination (median 13.8 μg/cm2, data 
not shown in Fig. 3) than other worker groups but taking into account 
the process and their low Cr biomarker levels these may mainly reflect 
Cr(III) exposure. 
3.3. Correlations between the different exposure metrics 
Fig. 4 shows heatmaps on the Spearman correlations between 
different markers of exposure. When all the worker groups were com-
bined the correlations between different exposure markers remained 
low (ρ < 0.5). When chrome platers were analysed separately, high 
positive correlations were observed between U–Cr levels and respirable 
air Cr(VI) levels or between U–Cr levels and wipe sample Cr levels (ρ =
0.805, ρ = 0.746, respectively). Air levels (inhalable and respirable Cr 
(VI) outside RPE showed high correlation also with hand contamination 
(ρ ≥ 0.8) in platers. In welders, high positive correlations were observed 
between U–Cr and respirable Cr(VI) outside RPE (ρ = 0.745). Correla-
tions between different biomarkers (U–Cr, RBC-Cr and EBC-Cr) were 
generally low (ρ < 0.5). 
3.4. Country differences 
Since there were differences in the type of companies sampled in 
each country, only limited comparisons of the results among the coun-
tries were possible. Since France and the Netherlands have implemented 
Table 4 
Comparison of post-shift U–Cr to P95 level observed in controls and to BLVs from France and Finland.   
Post-shift samples, n (%), exceeding the specific level 
Job title P95 of outwith company controls, 
0.44 μg/g creatinine) 
P95 of all controls, 1.35 
μg/g creatinine) 
French BLV of 2.5 μg/l (1.8 
μg/g creatinine) 
>Finnish BLV of 10 μg/l (7.8 
μg/g creatininea) 
Bath plating workers (n = 90) 70 (78) 36 (40) 31 (34) 4 (4) 
Chromate paint applications (n = 45) 30 (67) 15 (33) 11 (24) 1 (2) 
Machining workers (n = 38) 31 (86) 16 (44) 7 (18) 0 (0) 
Welders (n = 189) 127 (67) 49 (26) 34 (18) 0 (0) 
Thermal spraying (n = 5) 2 (40) 1 (20) 1 (20) 0 (0) 
Steel production (n = 10) 9 (90) 5 (50) 2 (20) 0 (0) 
Maintenance and laboratory workers in 
plating companies (n = 8) 
3 (38) 1 (13) 0 (0) 0 (0)  
a Creatinine corrected value calculated using the observed mean creatinine content of 1.29 g/l in post-shift worker samples. 
Fig. 2. RBC-Cr results of controls and different 
worker groups. Worker groups with n ≤ 10 are not 
presented. RBC-Cr data are adjusted for hematocrit 
value 2 (measured after the washing steps). * Workers 
vs. within company controls, ** workers vs. outwith 
company controls, *** welders vs. outwith company 
controls (note that RBC-Cr levels in welders were 
statistically significantly lower when compared to the 
outwith company controls). Box plots: The bottom 
and top of the box are, respectively, the 25th and 
75th percentiles, and the horizontal line inside the 
box is the median (50th percentile). The lower and 
upper ends of the whiskers are the 5th and 95th 
percentiles, respectively. The solid diamond is the 
geometric mean.   
Table 5 
Summary of the air Cr(VI) measurements in μg/m3 (personal measurements, 
outside RPE). Data from worker groups with number of measurements <5 not 
presented.  
Job title Inhalable Cr(VI) levels, 
median; 95th percentile (n) 
Respirable Cr(VI) levels, 
median; 95th percentile (n) 
Bath plating 
workers 
0.43; 5.13 (57) 0.09; 2.28 (54) 
Chromate paint 
applications 
5.61; 154 (7) n.d. 
Machining workers 0.10; 0.41 (15) 0.03; 0.05 (10) 
Welders 0.50; 4.06 (107) 0.11; 22.31 (20) 
Thermal spraying 9.63; 21.04 (5) 0.06; 0.10 (5) 
n.d. - not determined. 
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lower OELs for Cr(VI) than other countries it was interesting to see 
whether these countries showed lower exposure levels. For bath platers, 
exposure levels as measured by U–Cr (post-shift) and air inhalable Cr(VI) 
were lower in France when compared to the data from other countries 
(p < 0.001, Mann-Whitney test, data not shown). When data from 
France and Netherlands were combined and compared to the data from 
other countries, U–Cr levels showed borderline significantly lower levels 
in these two countries (p = 0.049) whereas the difference in air inhal-
able Cr(VI) levels was not statistically significant. RBC-Cr and EBC-Cr 
(VI) levels showed significantly lower levels (p < 0.001) in chrome 
platers when the combined results of France and the Netherlands were 
compared to the data from other countries. It must be, however, noted 
that the sample size in France and Netherlands was only 20 and 19 for 
platers, respectively. For welders it was possible to compare French data 
to the data from other countries (Dutch data were not available from 
welders). Similar trend as in chrome platers was not seen in welders: on 
the contrary, French welders showed higher U–Cr and RBC-Cr levels 
when compared to the respective data in other countries (p = 0.008 and 
p < 0.001, respectively, data not shown). 
4. Discussion 
4.1. Exposure of control population 
An important finding of this study is that in addition to those workers 
directly exposed to Cr(VI) in plating, welding or other surface treatment 
activities, some of the office workers recruited as controls from these 
companies might have been indirectly exposed to Cr(VI). This can be 
seen by the significantly higher U–Cr levels in the within company 
controls when compared to the outwith company controls (see Table 2). 
This might reflect bystander exposure of some of the industrial controls 
working in these companies. However, it should be noted that the group 
of “outwith company controls” consisted of only Portuguese and Finnish 
workers for U–Cr and for EBC-Cr(VI) Finnish and UK workers, whereas 
“within company controls” were from Belgium, Poland, France, 
Luxembourg and the Netherlands, and for EBC-Cr(VI) and RBC-Cr also 
from Italy. Thus, contribution of country differences in background Cr 
(VI) (or Cr(III)) exposure cannot to be excluded. The general population 
is exposed to Cr species (both trivalent and hexavalent chromium) via 
the diet, ambient air and drinking water (IPCS, 2009, 2013). Therefore, 
environmental pollution in the area of residence may have some impact 
on the levels observed in controls. According to the study by Morton 
et al. (Morton et al., 2014) from UK, P95 of occupationally non-exposed 
population was 1.31 μg/g creatinine, which is only slightly lower than 
the P95 observed in “within company controls” in our study. Median 
U–Cr level in the Morton et al. study was 0.42 μg/g creatinine. On the 
other hand, in an Italian study (Aprea et al., 2018) GM and P95 levels 
were 0.218 and 0.963 μg/g creatinine whereas Hoet et al. (Hoet et al., 
2013) reported median and P97.5 levels of 0.109 and 0.341 μg/g 
creatinine, respectively, among Belgian occupationally non-exposed 
population. Overall, although there might be some differences related 
to the environmental exposure, these might not fully explain the high 
levels observed in some of our “within company controls”. Thus, office 
persons working in the companies but not involved in the production 
process may also be exposed to Cr at their workplace. This finding might 
imply that not all the exposures are being identified and this can have an 
impact on the exposure and risk assessment results, which may have 
consequences in defining the proper RMMs. Smoking and gender 
seemed to have either no or only a minor effect on the internal chro-
mium exposure. This is in accordance with earlier studies (Aprea et al., 
2018; Hoet et al., 2013; Morton et al., 2014). Slightly higher creatinine 
corrected U–Cr levels in females might be at least partly explained by the 
creatinine correction as male controls had higher creatinine levels than 
female controls (data not shown). The higher proportion of females in 
our control group when compared to the exposed workers is, however, 
unlikely to have a significant impact on the comparison between 
exposed workers and controls, which show clearly elevated U–Cr levels 
in occupationally exposed workers compared to the controls. 
4.2. Exposure of chrome bath platers 
Our overall results suggest that workers performing electrolytic 
plating in baths are the group with highest internal exposure to Cr(VI). 
In the plating process Cr(VI) exposure occurs as ultrafine condensation 
droplets containing Cr(VI) are emitted from warm baths. These workers 
showed significantly elevated U–Cr, RBC-Cr and EBC-Cr(VI) levels when 
compared to the controls. In addition to elevated post-shift U–Cr levels, 
pre-shift urinary levels were significantly elevated when compared to 
Fig. 3. Hand contamination of workers measured as 
wipe samplings before the beginning of the shift and 
during the shift before any break (e.g. before hands 
were washed in the lunch break) and post-shift. Sum 
of the samples taken during the shift and post-shift 
was calculated and presented as a “shift sum”. Only 
worker groups with n > 10 are included in the figure. 
Box plots: The bottom and top of the box are, 
respectively, the 25th and 75th percentiles, and the 
horizontal line inside the box is the median (50th 
percentile). The lower and upper ends of the whiskers 
are the 5th and 95th percentiles, respectively. The 
solid diamond is the geometric mean.   
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Fig. 4. Heatmap on Spearman correlation coefficients. a) All worker groups combined b) Chrome platers and c) welders. Note that EBC-Cr(VI) is not included in 
correlations in welders because of the low number of samples exceeding LOQ. 
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the controls. This may reflect the specific kinetics of chromic acid 
derived from the previous working week. Elevated pre-shift U–Cr of up 
to one week were previously reported to occur in chrome platers with 
skin burns resulting from occupational accidents (Matey et al., 2000). A 
recent study suggested fast kinetics to explain an increase from pre-to 
post-shift U–Cr within one work period in a group of electroplating 
workers and, additionally, an increase of the average pre-shift U–Cr level 
from Monday to Friday by 45%, indicating slower kinetics (Remy et al., 
2021). 
In addition to inhalation exposure, also the observed Cr contami-
nation (measured as total Cr) in the hand wipes may be a contributing 
factor to explain the systemic exposure of bath platers to Cr. In our 
study, we observed high correlations between urinary Cr levels and wipe 
sample results. There are three potential explanations that may each by 
itself or combined explain what we observed: First, chromates may be 
skin absorbed but so far, such effects have only been reported in workers 
suffering from serious accidents where tissue burns may have caused 
breaches in the skin barrier. Second, the skin contamination could have 
resulted in hand-mouth contact as a potential secondary uptake route. 
Third, it is also possible that the observed association is not causal but 
just reflecting the common source of airborne particles that can be 
inhaled as long as they are airborne but may later settle down on sur-
faces on the workplace to be picked up skin exposure in our hand wipes. 
The urinary levels observed in this study in bath platers are very 
similar to those reported in the study by Beattie et al. (2017), which 
contained 354 UK electroplating workers showing mean U–Cr of 1.2 
μg/g creatinine and P90 level of 4.9 μg/g creatinine. Similar U–Cr levels 
were reported also in an Italian study (Goldoni et al., 2010) whereas 
studies from Asia and Brazil showed clearly higher exposure levels than 
those observed in European studies (summarized in a systematic review 
by (Verdonck et al., 2021). 
Our results from RBC-Cr and EBC-Cr(VI) measurements also support 
the higher internal exposure of bath platers when compared to the other 
worker groups. There are only few earlier studies on the RBC-Cr or EBC- 
Cr(VI) levels in electroplaters. Goldoni et al. (Goldoni et al., 2010) report 
median RBC-Cr levels of 3.4 μg/l (range 1.2–5.8) in 14 Italian electro-
platers, which are slightly lower than observed in our study showing 
median levels of 4.34 and P95 of 8.88 μg/l. A study by Zhang et al. 
(2011) from China shows RBC-Cr levels of 4.41 μg/l (median, range 
0.93–14.98) among 157 electroplater workers. EBC-Cr(VI) levels have 
been measured earlier by Goldoni et al. (Goldoni et al., 2010) reporting 
median levels of 0.5 μg/l (range nd-10.1). In addition, Leese et al. (Leese 
et al., 2017) also reported EBC-Cr(VI) levels among a group of Cr(VI) 
exposed workers including chrome platers and measured median levels 
of 0.91 μg/l. Both these studies are one order of magnitude higher than 
the levels measured in our study. However, Goldoni et al. (Goldoni et al., 
2010) reported air measurements one order of magnitude higher than 
measured in our study, with a geometric mean of 2.6 μg/m3 and 3.6 
μg/m3 for Cr(VI) and total chromium, respectively. In our study, geo-
metric mean of inhalable Cr(VI) level in bath plating was 0.34 μg/m3. 
Air measurements were not collected by Leese et al. (Leese et al., 2017). 
4.3. Exposure of stainless steel welders 
Welders showed very similar external exposure to Cr(VI) to chrome 
platers (see Table 5 on air levels). However, internal exposure to Cr, 
measured as U–Cr, RBC-Cr and EBC-Cr(VI) remained lower when 
compared to the platers. According to the questionnaire, more than 50% 
of welders used RPE when performing welding, which may partly 
explain lower internal exposure of welders when compared to the 
chrome platers. Another explanation may be lower bioavailability of Cr 
(VI) particles formed during welding (Walter et al., 2015). In welders 
significant hand contamination was observed but the more frequent use 
of PPE when compared to bath platers might contribute to avoid expo-
sure by ingestion due hand-to-mouth contact. Since dermal wipe sam-
ples were measured only for total Cr it is not possible to estimate the 
proportion of Cr(VI) of total Cr levels in different work tasks. Our results 
in welders are in accordance with the biomonitoring results reported 
recently in literature in Europe. According to the review by (Verdonck 
et al., 2021) median U–Cr levels in welders were between 0.74 and 0.9 
μg/g creatinine in recent studies performed in Germany and in Italy 
(Pesch et al., 2018; Riccelli et al., 2018) whereas recent Polish study 
showed somewhat higher urinary levels (median 3.81 μg/g creatinine) 
(Stanislawska et al., 2020). In our study median post-shift U–Cr level 
was 0.68 μg/g creatinine. An earlier study by Weiss et al. (2013) re-
ported on RBC-Cr levels among 16 highest exposed welders with median 
RBC-Cr level of 1.95 μg/l (P75 2.37 μg/l) and U–Cr level 9.95 μg/g 
creatinine (P75 38.99 μg/g creatinine). These were clearly higher ex-
posures than observed in our study (median RBC-Cr 0.4 μg/l and P75 
1.12 μg/l). 
4.4. Exposure in machining and painting applications 
Machining workers included in this study were operating either in 
companies performing bath plating operations or other surface treat-
ment activities. Their personal air measurements and dermal total Cr 
contamination were lower than bath platers and welders but U–Cr and 
RBC-Cr levels were between those reported for the platers and welders. 
Other activities performed in the companies might have had an impact 
on the exposure of these workers who might have been performed also 
other tasks in the company in the days preceding the measurement, 
although in the day of measurements the main tasks were machining 
tasks. 
Paint applications and thermal spraying showed highest air Cr(VI) 
levels when measured outside RPE. However, the use of RPE in these 
tasks reduced exposure effectively to clearly a lower level than observed 
in platers. Paint applications included spray painters, paint removal and 
application with different contents of Cr(VI) e.g. in manual brush 
painting. Biomonitoring of these workers in combination with air 
measurements is of special importance to ensure the effectiveness of 
personal protective equipment but also to identify the role of other 
exposure routes besides inhalation. Although dermal total Cr contami-
nation over the working day was also observed in these workers, it was 
clearly lower than that observed in bath platers and in welders. This 
aspect might be explained by the fact that the tasks undertaken by this 
group of workers imply commonly the use of protective clothes and 
gloves due to the simultaneous handling of solvents and other chemicals. 
4.5. Use of RPE in the prevention of exposure to Cr(VI) 
Use of RPE seems to reduce internal Cr exposure in chromate paint 
applications to a clearly lower level than in bath plating operations. In 
our study, chrome plating workers generally did not wear RPE, or used 
RPE only in some short, specific tasks like sampling: only 16% reported 
to use RPE in bath operations, and only 23% reported to use RPE in any 
tasks during the day of sampling (data not shown). This is likely to 
reflect the current recommendations on the risk management at chrome 
bath plating: in the applications for authorization for the use of Cr(VI) 
for functional or decorative plating in baths, use of RPE has been usually 
recommended mainly for tasks involving handling of solid chromates (e. 
g. weighting and mixing and re-filling baths with solid chromates) or 
waste handling activities (ECHA, 2021). Less frequent use of RPE among 
bath platers may be one factor explaining the higher internal exposure of 
this sub-category when compared e.g. to welders, which showed very 
similar (or even slightly higher) inhalable air levels of Cr(VI). Impact of 
personal protection on the internal exposure in different exposure sce-
narios will be analysed further in detail in follow-up papers (in 
preparation). 
4.6. Compliance with guidance and limit values 
Since this study focused primarily on biomonitoring, there was some 
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variability in the air samples collected in different countries (Galea 
et al., 2021). Some laboratories were only able to measure total Cr from 
the air samples which limited the number of air samples informing 
specifically on air levels of Cr(VI). These measurements are discussed in 
more detail in the follow-up paper on industrial hygiene measurements. 
However, a significant number of Cr(VI) measurements were performed 
in bath platers and in welders. The use of Cr(VI) in bath plating falls 
under EU REACH authorization and several authorizations have to date 
been granted under REACH for this use. Some of these authorizations are 
so-called “up-stream” authorizations covering possibly hundreds of 
“down-stream” users whereas some are covering only one or few sites. In 
some up-stream uses reasonable worst-case exposure of workers in bath 
plating processes have been estimated to be 2 μg/m3 (inhalable Cr(VI) as 
8 h TWA) (ECHA, 2021). In our study, the majority of exposures were 
below 1 μg/m3 with geometric mean being 0.34 μg/m3 and median 0.43 
μg/m3. However, P90 and P95 levels were 3.4 and 5.13 μg/m3, 
respectively, suggesting that there is a need for more effective RMMs to 
achieve low levels in all instances. 
The same conclusion can be made also on the basis of biomonitoring 
results. Correlation equations published by Lindberg and Vesterberg 
(Lindberg and Vesterberg, 1983) and Chen et al. (Chen et al., 2002) have 
been used to set biological limit values of 2.5 μg/l (1.8 μg/g creatinine) 
and 10 μg/l (7.8 μg/g creatinine) for Cr(VI) corresponding to OELs of 1 
or 5 μg/m3 in electroplating activities, respectively (see Table 4). In our 
study, 34% of platers samples exceeded the level of 1.8 μg/g creatinine, 
but the level of 7.8 μg/g creatinine was exceeded only in four workers. 
It should be noted that a significant proportion of the total exposure 
to Cr in chrome plating activities may be related to dermal contamina-
tion which is suggested by high Spearman correlation coefficients be-
tween U–Cr and wipe sample results. Significant contribution of dermal 
contamination has been noted already in earlier studies in the electro-
plating sector (Lumens et al., 1993; Mäkinen and Linnainmaa, 2004). 
Systemic uptake of Cr has been only described with skin burns caused by 
chromic acid resulting in retention in RBC and elevated urinary excre-
tion levels over several weeks (Boloorchi et al., 2007; Matey et al., 2000; 
Terrill and Gowar, 1990). However, significant uptake of Cr may also be 
caused by hand-to-mouth contact resulting inadvertent ingestion 
(Cherrie et al., 2006). 
Cr(VI) absorbed into the skin may cause skin sensitization, and 
ingested Cr(VI) may increase the risk of gastrointestinal cancers (ECHA, 
2013). Systemically absorbed Cr(VI) is also a reproductive toxicant but 
the exposure levels measured in the current study are well below the 
derived no effect level (DNEL) given by ECHA for the reproductive 
toxicity of Cr(VI) (ECHA, 2015). The most significant risk at these 
exposure levels is, however, the respiratory tract carcinogenicity which 
is mainly related to the amount of chromium inhaled. At air levels of 
1–5 μg Cr(VI)/m3, lung cancer risk is still in the range of 4–20 extra 
cancers/1000 workers (ECHA, 2013; SCOEL, 2017). 
When looking at the welders’ data, an important aspect to note is 
that based on our data, the derogation given in EU Carcinogens and 
Mutagens directive (EU, 2004) for welding or plasma-cutting processes, 
with an OEL value of 25 μg/m3 until 5 years after the transposition date, 
seems unnecessary. The median inhalable Cr(VI) level in welders in this 
study was only 0.5 μg/m3 and even P95 level of inhalable Cr(VI) was 
below the proposed BOELV of 5 μg/m3. This suggests that it is already 
feasible to meet the requirements of EU Carcinogens and Mutagens 
Directive for welding and plasma-cutting processes, if the appropriate 
RMMs are in place. 
4.7. Application of different biomarkers 
In this study, we applied three different biomarkers of exposure: 
U–Cr, RBC-Cr and EBC-Cr(VI). U–Cr is a standard method used at 
workplaces to measure internal exposure to chromium. The weakness of 
this method is that it is unspecific and any significant exposure to Cr(III) 
may have an impact on U–Cr levels. In addition, there are significant 
background levels of U–Cr in the general population mainly due to the 
exposure to Cr(III) via e.g. food (Domingo et al., 2012; IPCS, 2009). 
Therefore, we explored also the applicability of more specific bio-
markers, RBC-Cr and EBC-Cr(VI), to assess the exposure to Cr(VI) at the 
current exposure levels. RBC-Cr is considered to reflect exposure spe-
cifically to Cr(VI) during the whole lifespan of the red blood cell (i.e. 120 
days). U–Cr reflects both past and recent exposure, which leads to daily 
accumulations through the working week. Studies in welders suggest a 
two or three stage process of elimination with half-lives of 7 h, 15–30 
days and 3–5 yrs (ATSDR, 2012). Studies in chrome platers have shown 
half-lives of 2–3 days followed by 1 month (Lindberg and Vesterberg, 
1989). The kinetics of EBC-Cr(VI), on the other hand, is currently un-
known. However, Goldoni et al. (Goldoni et al., 2010) reported Cr(VI) 
levels in EBC samples at least 36 h after exposure. The low correlations 
observed between U–Cr/EBC-Cr(VI) and RBC-Cr are likely reflecting 
different kinetics. Therefore, biomarkers might provide complementary 
information and their choice should be based on the information needed 
to keep improving the RMMs in place. The role of these additional 
biomarkers will be further analysed in follow-up publications (in prep-
aration) to define their role more precisely in the assessment of occu-
pational exposure to Cr(VI). However, the strong correlations observed 
between U–Cr levels and air Cr(VI) in platers and welders support the 
use of U–Cr as a primary method for the biomonitoring of Cr(VI) 
exposure at workplaces. In this study we collected paired urine samples 
(both pre-shift and post-shift samples) for U–Cr measurement to calcu-
late urinary ΔCr within persons. When aggregated on the group level, 
the increase in U–Cr levels was demonstrated in most worker groups 
suggesting recent occupational exposure to Cr between the samplings. 
4.8. The strengths and limitations of the study 
This biomonitoring study on occupational exposure to Cr(VI) has a 
unique set-up including multiple countries producing biomonitoring 
and industrial hygiene information on exposure to Cr(VI) using 
harmonized protocols. The HBM4EU chromates study design allowed to 
achieve a number of participants which is typically more difficult to 
recruit in national occupational health studies. The study was focused on 
three major sectors with exposure to Cr(VI); electrolytic Cr(VI) plating in 
baths, other surface treatment activities and welding. However, vari-
ability of the tasks undertaken by the participants resulted in some 
smaller groups of workers being assigned. Overall, we achieved the 
target of including 400 exposed workers and 200 controls. There were 
no specific target numbers for the enrollment of participants repre-
senting specific job categories and it was dependent on those companies 
(and workers) who consented to participate in the campaign. Thus, the 
highest numbers of workers recruited were performing welding tasks 
and the second highest group was chrome bath platers. The “other 
surface treatment” group was more heterogenous and included workers 
engaged in painting procedures (removing old paint and application of 
new paint), machining tasks as well as a few thermal sprayers and some 
mainly involved in steel milling process. These workers were considered 
as separate groups. 
The challenges and lessons learned from this kind of multi-center 
occupational health study have been discussed in detail in the paper 
by Galea et al. (2021). Several practical aspects were highlighted for 
improvement in future multi-center occupational studies, e.g., more 
thorough/earlier training on the implementation of SOPs for field re-
searchers, training on the use of the data entry template, as well as 
improved company communication and interaction. 
5. Conclusions and recommendations 
This study gives information on the current occupational exposure to 
Cr(VI) in some industrial sectors in nine countries in Europe. It shows 
that among the studied industry sectors the highest internal exposures 
are still related to the use of Cr(VI) in electrolytic bath plating and, for 
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example, in stainless steel welding the exposure is clearly lower when 
compared to plating activities. 
Our results suggest significant association of dermal total Cr 
contamination to the internal exposure to chromium in all worker 
groups. This emphasizes the role of biomonitoring beside air measure-
ments in the control of Cr(VI) exposure at workplaces since it allows 
better to understand which exposure routes are contributing to the total 
exposure. 
Although being a non-specific biomarker, U–Cr showed its value as a 
first approach for the assessment of total, internal exposure. Differences 
in the kinetics and low correlations between U–Cr and other studied Cr 
(VI) exposure biomarkers indicate that these approaches may not be 
interchangeable but rather complementary. Thus, although U–Cr is 
practicable for routine monitoring of Cr(VI) exposure in occupational 
health, RBC-Cr and EBC-Cr(VI) may provide additional information 
when more specific information on exposure is needed. 
Our results also found elevated U–Cr levels in pre-shift samples 
supporting low elimination/excretion of chromium from the body. In 
occupational health practice, paired samples (pre-shift in the beginning 
of the workweek – post-shift in the end of the workweek) are recom-
mended to be used to give information on the recent exposure, which 
can be linked to exposure in specific tasks performed. Potential exposure 
of bystanders needs also to be further studied and considered in com-
panies’ health surveillance regimes. 
This study showed that occupational biomonitoring studies can be 
conducted successfully by multi-national collaboration. Using a similar 
approach in future studies may lead to comparable data that can then be 
used to analyse trends in exposure over time. This solution can also serve 
as a model for national studies and for other chemicals of concern. 
Additionally, these kinds of studies can provide relevant and useful in-
formation to support policy actions aiming to reduce occupational 
exposure to chemicals. 
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Terrill, P.J., Gowar, J.P., 1990. Chromic acid burns; beware, be aggressive, be watchful. 
Br. J. Plast. Surg. 43 (6), 699–701. 
Verdonck, J, Duca, R.C, Galea, K.S., Iavicoli, I., Poels, K., Töreyin, Z.N., Vanoirbeek, J., 
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